Ceftibuten (Cedax)

05/01/1990 - "[Therapeutic efficacy of ceftibuten in chronic respiratory tract infections]."
07/01/1995 - "Moreover, ceftibuten has been shown to be useful in the treatment of acute lower respiratory tract infections. "
04/01/2000 - "Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study."
07/01/1995 - "This study suggests that ceftibuten can be administered orally, once daily in an adult dose of 400 mg or a pediatric dose of 9 mg/kg, to treat respiratory infections caused by the most common pathogens."
08/01/1999 - "The results support the activity of ceftibuten in the treatment of upper and lower respiratory tract infections."

07/25/1999 - "A prospective, comparative, multicentre trial was performed to study the efficacy and safety of ceftibuten in respiratory and complicated urinary tract infections. "
01/01/2022 - "In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales."
01/01/1993 - "These findings could help to explain the efficacy showed by ceftibuten in the treatment of respiratory and urinary tract infections when administered once daily."
08/01/1991 - "The potent in vitro activity of ceftibuten in conjunction with its favorable pharmacokinetic profile render this new molecule an attractive candidate for the treatment of respiratory and urinary tract infections sustained by susceptible pathogens."
03/01/1991 - "Treatment of acute uncomplicated urinary tract infection with ceftibuten."

03/01/1993 - "Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study."
09/29/2000 - "Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children."
09/29/2000 - "this study on young children with recurrent otitis media has shown no statistical difference between ceftibuten given once daily for 5 and 10 days as determined on day 40. "
07/01/1995 - "Members of the Ceftibuten Otitis Media International Study Group."
07/01/1995 - "Members of the Ceftibuten Otitis Media United States Study Group."

12/01/1992 - "In summary, once-daily ceftibuten can be considered a safe and effective treatment for acute bacterial sinusitis."
05/01/1999 - "Treatment of acute sinusitis in childhood with ceftibuten."
01/01/2001 - "[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]."
12/01/1992 - "The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis."
01/01/2001 - "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis. "

07/01/1995 - "Members of the Ceftibuten Pharyngitis International Study Group."
12/01/1996 - "The presence of high ceftibuten concentrations in tonsillar tissue suggests that a once-daily regimen may be effective in treating tonsillitis and pharyngitis."
10/01/2000 - "To compare the safety and efficacy of a short course (5 days) of ceftibuten vs. azithromycin for 3 days for treatment of group A beta-hemolytic streptococcal (GABHS) pharyngitis in children. "
10/01/2000 - "A multicenter, open label, prospective, randomized trial in which patients > or =3 to < or =16 years of age with proven GABHS pharyngitis were randomized to receive either once daily ceftibuten for 5 days or azithromycin for 3 days. "
07/01/1995 - "These data suggest that once daily ceftibuten is as safe as and more effective than three times daily penicillin V for the treatment of group A beta-hemolytic streptococcal pharyngitis."